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A B S T R A C T
Acrocomia aculeata, popularly known as “bocaiúva”, is a species used for nutritional purposes and for
the treatment of various diseases, as it has, among other things, high levels of antioxidant compounds.
This study aimed to assess the toxicological proﬁle of A. aculeata, through acute and subacute toxicity
tests. Male and female rats (Wistar) received by gavage 2000 mg/kg of oil extracted from the pulp of
A. aculeata (OPAC) for the acute toxicity test and 125, 250, 500 or 1000 mg/kg of OPAC for subacute tox-
icity test. In the acute toxicity study no mortality or behavioral changes were observed in rats treated
with 2000mg/kg, indicating that the LD50 is higher than this dose. In the subacute toxicity test, the tested
doses produced no signiﬁcant changes in hematological, biochemical or histopathological parameters
in the animals exposed. These results demonstrate the absence of acute and subacute toxicity after oral
exposure to A. aculeata oil in rats. However, further studies in animals and in humans are needed in order
to have suﬃcient safety evidence for its use in humans.
© 2014 Elsevier Ltd. All rights reserved.
1. Introduction
Natural products have been the target of numerous studies for ob-
tainingactivemoleculeswith therapeutic potentials. Besides thediversity
of medicinal species found, the use of plantswith phytotherapic prop-
erties has increased due to the belief that everything that is “natural”
does not cause adverse health effects (Oliveira et al., 2011). However,
some species selected for medicinal use underwent chemical, toxici-
ty or pharmacological studies to evaluate their safety and eﬃcacy (Melo
et al., 2011; Reyes-García, 2010).
Acrocomia aculeata (Jacq.) Lodd. ex Mart., popularly known as
“bocaiúva” or “macaúba”, is a plant widely distributed in theMidwest
region of Brazil (Lorenzi, 2006). Their use has recently increased due
to important features in the prevention of diseases. Besides its
medicinal use, the pulp of A. aculeata can be used as food, cosmet-
ics and to produce energy (Ramos et al., 2008). According to popular
knowledge, this medicinal plant has been used to treat respirato-
ry diseases, and has laxative, analgesic and restorative properties
(Lorenzi, 2006). In addition, pharmacological studies have shown
its reductive effects on glucose and total cholesterol (Silva, 2012).
Regarding the chemical composition, studies have shown high
levels of β-carotene (Ramos et al., 2008; Rocha et al., 2013;
Sanjinez-Argandoña and Chuba, 2011), α-tocopherol (Coimbra and
Jorge, 2011, 2012) and oleic acid (Amaral et al., 2011; Mariano et al.,
2011) in the A. aculeata pulp performed by high-performance liquid
chromatography and open column procedures. Though widely used
by the population and favored for its nutritional and medicinal-
chemistry purposes, little information is available in the literature
on the therapeutic or toxic effects of this species. Thus, the aim of
this study is to evaluate the toxicological proﬁle of the oil ex-
tracted from the pulp of A. aculeata after a single oral administration
or 28 consecutive daily administrations.
2. Materials and methods
2.1. Plant material and preparation of oil
Mature fruits of the palm A. aculeata were collected (latitude 22°13′18.54″
south and longitude 54°48′23.09″ west) in September 2013. A voucher specimen
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was authenticated by Dr. LS Nogueira, and deposited (No. 2169) in the Herbarium
of the Federal University of Grande Dourados. Access to the plant samples used for
research has been authorized by the National Counsel of Technological and Scien-
tiﬁc Development, Brazil (No.010653/2013-9).
The fruits of A. aculeata were washed, peeled and the pulp scariﬁed. The pulps
were then oven dried with ventilation at 50 °C for 2 hours. After drying, 500 g of
sample were weighed and added as a solvent 1 L of hexane, leaving the mixture to
stand under artiﬁcial light for 7 days. The hexane mixture was then ﬁltered and con-
centrated at 57 °C in a rotary evaporator (Oetterer et al., 2006).
2.2. Determination of the acid values, transesteriﬁcation and characterization of
methyl monoesters
The OPAC (200 g) was weighed andmixed with methanol (60mL) and KOH (2 g).
The mixture was stirred and heated to 60 °C. The reaction was followed by thin-
layer chromatography (TLC). After the oil consumption, the solution was decanted
for 1 hour to separate the glycerin phase. The methanolic phase was treated with
distilled water (10 mL) plus 10% NaCl (10 mL), dried with MgSO4, and ﬁnally ﬁl-
tered and concentrated in a rotaevaporator (Silva, 2012).
Gas chromatography (GC), using detector-mass spectrometry (DMS) and a ﬂame
ionization detector (FID), was performed to determine the chemical composition of
the methyl fatty acid monoesters. The GC/DMS was performed using the chromato-
graph Varian model 431-GC210MS, according to the following conditions: Column:
ZB-5 ms 30 m × 0.25 mm; Carrier gas: Helium 99.99%; Flow gas: 3.0 mL/min; Mass
Spectrometry: ionization electron-impact mode SCAN-m/z 40–700; Oven temper-
ature: 50 °C/1 min – 5 °C/1 min – 248 °C/6 min; Sample injection: mode split 50:1;
Sample volume: 0.1 μL; and standard fatty acid methyl esters. The chromatograph-
ic conditions of the GC/FID were as follows: Column: ZB-Wax (5% phenyl
Dimethylpolysiloxane); Carrier gas: Helium 99.99%; Flow gas: 3.0 mL/min; Temper-
ature of detector: 250 °C; Oven temperature: 50 °C/1 min – 5 °C/1 min – 248 °C/
6min; Sample injection: mode split 50:1; Sample volume: 0.1 μL; and standard fatty
acid methyl esters.
Values were determined based on the comparison between the times of reten-
tion and the proﬁle of fragmentation of fatty acid methyl esters of samples analyzed
under the same conditions. Quantiﬁcation was performed by converting the per-
centages of peak areas in relation to the percentage of mass (% fatty acid = peak area
of each fatty acid × 100/sum of all peak areas of fatty acids) (Silva, 2012).
2.3. Animals
Adult male and female Wistar rats (8–12 weeks, weighing 170–270 g) from the
Federal University of Mato Grosso do Sul, were maintained under controlled tem-
perature (23 °C), with a constant 12 h light–dark cycle and free access to food and
water. Ten animals (females) were used for acute toxicity test and 50 animals (females
and males) for the subacute toxicity test (OECD, 2008a, 2008b). The experimental
procedures were in accordance with the Ethical Principles in Animal Research and
approved by the Committee for Ethics in Animal Experimentation at the Universi-
ty Federal of Grande Dourados (number: 028–2013).
2.4. Toxicity studies
Acute and subacute toxicity studies were based on the OECD (Organisation for
Economic Co-operation and Development) – Guidelines 425 and 407 (OECD, 2008a,
2008b).
2.4.1. Acute toxicity
The oil extracted from the pulp of A. aculeata (OPAC) was administered by gavage,
at a dose of 2000 mg/kg, to one female (OECD, 2008a) under fasting for 8 hours. Se-
quentially, at intervals of 48 hours, the same dose was administered to four females,
totaling ﬁve treated animals (Group: OPAC 2000mg/kg). In parallel, ﬁve females were
treated with vehicle (saline with Tween® 80 2%) in order to establish a compara-
tive negative control group (OECD, 2008a).
The animals were observed periodically during the ﬁrst 24 hours after admin-
istering the oil and then once a day for 14 days. The ﬁve parameters of the Hippocratic
screening (Malone and Robichaud, 1962) were analyzed: conscious state (general
activity); activity and coordination of motor system and muscle toning (response
to tail touch and grip, straightening, strength to grab); reﬂexes (corneal and headset);
activities on the central nervous system (tremors, convulsions, straub, sedation, an-
esthesia and ataxia) and activities on the autonomic nervous system (lacrimation,
cyanosis, ptosis, salivation and piloerection). The water and feed consumption and
body weight were also recorded daily (OECD, 2008a).
At the end of the observation period, all animals were anesthetized (Ketamina
and xylazine, 25 and 10 mg/kg, respectively) and organs (heart, lung, spleen,
liver, kidney, uterus and right ovary) were removed, weighed and examined
macroscopically.
2.4.2. Subacute toxicity
The animals were divided into ﬁve experimental groups (n = 10 animals/
group, ﬁvemales and ﬁve females). Three different doses of OPAC (125, 250 or 500mg/
kg) were administered per group, orally (gavage), daily for 28 consecutive days. The
control group received only the vehicle (saline with Tween® 80 2%). Another group
(Satellite) received the maximum dose of 1000 mg/kg of OPAC for 28 days and re-
mained untreated for 14 more days. It is important to use a satellite group for
observation of reversibility, persistence, or delayed occurrence of toxic effects related
to the administration of the test substance. The doses were chosen based on the Guide-
line 407 from OECD (Repeated Dose 28-Day Oral Toxicity Study in Rodents) (OECD,
2008b).
During treatment, daily body weight, food and water consumption, and possi-
ble signs of toxicity were observed and recorded, following the hippocratic screening.
Clinical examination was performed once daily. At the end of the observation period,
all animals were anesthetized (Ketamina and xylazine, 25 and 10 mg/kg, respec-
tively). Blood sampleswere collected by cardiac puncture for subsequent hematological
and biochemical analysis.
The following biochemical parameters were analyzed: bilirubin direct and total,
cholesterol, electrolytes (sodium, potassium and calcium), markers of renal func-
tion (blood urea nitrogen and creatinine) and liver (alanine aminotransferase and
aspartate aminotransferase) and protein proﬁle (albumin, total protein and globu-
lin) using Cobas Integra 400 Plus using commercial kits (Roche). Hematological analysis
measured leukocyte count total and differential, erythrocytes and platelets, besides
the levels of hemoglobin, hematocrit and red cell distribution width, with the unit
XT-4000i (Sysmex).
After collecting blood, the vital organs (heart, lung, kidney, liver and spleen) and
reproductive organs (testis, epididymis, vas deferens, prostate, uterus and ovary) were
weighed. Samples of all organs were ﬁxed in 10% buffered formalin, embedded in
paraﬃn, sectioned at 5 μm, and stained with hematoxylin and eosin and exam-
ined under light microscopy (Martey et al., 2010). Histological analysis aimed to assess
tissue integrity of the organs. The parameters analyzed were: degeneration, necro-
sis, apoptosis, leukocyte inﬁltration, congestion, extravasation of blood and ﬁbrosis
(Cunha et al., 2009).
2.5. Statistical analysis
Results were expressed as mean ± standard error of the mean (SEM). Student’s
t-test was used for comparison between two experimental groups (acute toxicity).
The differences between groups of subacute toxicity were determined by analysis
of variance (one-way ANOVA) followed by Dunnett’s test. Differences were consid-
ered signiﬁcant at p < 0.05.
3. Results and discussion
Vegetable oils rich in bioactive compounds are receiving
growing interest due to their role in disease prevention through diet
improvement (Coimbra and Jorge, 2011). However, toxicological
studies are required to determine the toxicity and thus establish cri-
teria for the selection of a safe dose (Berenguer-Rivas et al., 2013;
Farsi et al., 2013). The present study may represent the ﬁrst study
that demonstrates the absence of toxicity of the oil extracted from
the pulp of A. aculeata, which can contribute to the safe use of this
species.
Our research group has determined the chemical composition
of fatty acid of methyl monoesters of the oil obtained from the pulp
of A. aculeata (OPAC) through gas chromatography (GC) using
methods of mass spectrometry detector (MS) and ﬂame ioniza-
tion detector (FI) (Traesel et al., 2014). The results are expressed in
Table 1.
According toMariano et al. (2011), the pulp oil of A. aculeata pres-
ents higher levels of monounsaturated fatty acids than those found
Table 1
Monounsaturated fatty acids composition of oil extract of A. aculeata pulp.
Monounsaturated
fatty acids
% Area ± standard
error (GC/MS)
% Area
(CG/FI)
Lauric 0.184 ± 0.019 0.250
Myristic 0.243 ± 0.086 0.070
Palmitoleic 2.016 ± 0.203 2.031
Palmitic – 20.587
Linoleic 2.605 ± 0.341 2.050
Linolenic – 0.311
Oleic 61.092 ± 2.731 71.305
Stearic 2.978 ± 0.631 2.614
Arachidonic 1.087 ± 0.194 0.154
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in other vegetable oils such as olive oil, soy, corn, cottonseed, sun-
ﬂower and ﬂaxseed. Amaral et al. (2011) determined the presence
of 69.07% of oleic acid in the pulp oil of A. aculeata. These data cor-
roborate the chemical characterization performed on the oil sample
used in this study, in which the predominance of oleic acid was iden-
tiﬁed by the GC/MS and GC/FI methods and points out the important
chemical composition of the oil studied. The higher levels of mono-
unsaturated fatty acid found in the present oil demonstrate a
potential to become a good source of oleic acid, which makes this
pulp oil the most suitable for human consumption, due to its prop-
erties compatible with other vegetable oils (Coimbra and Jorge, 2011).
Although we have not determined the carotenoids composi-
tion here, studies conducted by Hiane and Penteado (1989) and
Ramos et al. (2008) indicated large amount of carotenoids in the
pulp of A. aculeata. The authors emphasized the high potential of
β-carotene as precursor of vitamin A and as antioxidant, assisting
in the process of oxidative stress. Later, Coimbra and Jorge (2011)
identiﬁed the presence of carotenoids (β-carotene) and also to-
copherols (α-tocopherol) in A. aculeata.
A few edible oils extracted from vegetal species were evalu-
ated in relation to their toxicity. Some oils obtained from Piper
aduncum and Copaifera reticulate presented low toxicity after acute
and/or subacute exposure (Sachetti et al., 2009; Souza et al., 2008).
However, others presented some toxicity, such as the oils ob-
tained from Azadirachta indica, Drimys angustifolia and Drimys
brasiliensis (Deng et al., 2013; Gomes et al., 2013), which rein-
forces the need for toxicological evaluation of oils of medicinal
interest.
Changes in body and organ weights are a clear indicative of
damage caused by the substance test (Berenguer-Rivas et al., 2013),
while the hippocratic screening provides a general estimate of phar-
macological and toxicological nature (Lucio et al., 2000). After the
acute toxicity test, the dose of 2000mg/kg (limit test – OECD, 2008a)
of OPAC did not cause the death of any animal. The female rats
exposed presented no behavioral changes during the treatment
period, as well as no changes in water and food consumption and
ponderal evolution, in relation to the control group (Table 2). No ab-
normality was found in the organs at necropsy. There was no
statistical difference in the organs’ relative weights between treated
and control groups (Table 3). Thus, the oil tested falls in Class 5 (a
substancewith oral lethal dose (LD50) higher than 2000mg/kg), hence
considered of low toxicity (OECD, 2008a). The absence of any sign
of toxicity in the satellite group at the end of the 14-day observa-
tion period indicated that the OPAC showed no late toxic effects in
the test animals. Similar results were found of Copaiba oil-resin ob-
tained from C. reticulate. In this study, it was observed that the lethal
oral toxicity of this oil was estimated to be higher than 2000 mg/
kg, classiﬁed as category 5 according to OECD Guide 423, indicating
a certain safety margin associated with the use of copaiba as ther-
apeutic agent (Sachetti et al., 2009).
Table 2
Body weight gain and food and water consumption of rats treated orally with oil extract of A. aculeata pulp.
Acute toxicity Subacute toxicity
Control 2000 mg/kg Control 125 mg/kg 250 mg/kg 500 mg/kg Satellite
Female
Initial weight (g) 200.60 ± 8.08 200.00 ± 8.21 199.00 ± 6.98 176.50 ± 2,40 179.60 ± 2.32 174.75 ± 1.18 189.20 ± 8.61
Final weight (g) 223.00 ± 13.69 228.40 ± 14.95 240.60 ± 16.53 214.20 ± 8.01** 214.60 ± 8.53** 212.80 ± 8.07** 225.40 ± 18.00*
Body weight gain (%) 11.14 ± 4.51 14.22 ± 8.46 21.01 ± 4.17 23.78 ± 8.28 19.51 ± 4.20 23.05 ± 5.54 19.34 ± 5.91
Food intake (g/day) 130.21 ± 6.70 124.21 ± 7.27 118.67 ± 7.17 107.10 ± 13.62* 106.96 ± 10.81* 106.85 ± 15.78* 109.75 ± 9.97*
Water intake (mL/day) 201.42 ± 25.22 196.42 ± 24.44 195.00 ± 13.33 180.80 ± 18.85** 178.46 ± 10.82** 179.17 ± 9.89** 192.50 ± 18.33
Male
Initial weight (g) 252.80 ± 10.39 250.40 ± 9.64 248.80 ± 8.22 253.00 ± 9.98
Final weight (g) 333.00 ± 24.62 308.00 ± 29.89 311.20 ± 23.30 323.00 ± 29.53 248.80 ± 1.93
Body weight gain (%) 28.82 ± 4.42 22.92 ± 2.90 25.14 ± 4.49 28.35 ± 5.89 316.20 ± 5.16
Food intake (g/day) 148.46 ± 10.23 134.92 ± 7.53* 147.77 ± 9.93 147.71 ± 12.63 27.10 ± 2.01
Water intake (mL/day) 232.32 ± 20.02 205.71 ± 15.13** 230.00 ± 32.75 229.64 ± 22.84 147.46 ± 11.96
Values expressed as mean ± SEM, n = 5 animals/group.
* p < 0.05 (ANOVA/Dunnett’s test) compared with control group; ** p < 0.01 (ANOVA/Dunnett’s test) compared with control group.
Table 3
Relative organ weight (g/100 g of body weight) of rats treated orally with oil extract of A. aculeata pulp.
Acute toxicity Subacute toxicity
Control 2000 mg/kg Control 125 mg/kg 250 mg/kg 500 mg/kg Satellite
Female
Liver 4.61 ± 0.26 4.58 ± 0.39 3.88 ± 0.12 3.69 ± 0.17 3.64 ± 0.22 3.90 ± 0.14 3.63 ± 0.19
Kidney 0.45 ± 0.03 0.48 ± 0.05 0.39 ± 0.02 0.37 ± 0.01 0.39 ± 0.01 0.37 ± 0.00 0.37 ± 0.01
Spleen 0.20 ± 0.02 0.21 ± 0.01 0.18 ± 0.01 0.17 ± 0.01 0.17 ± 0.01 0.18 ± 0.01 0.16 ± 0.01
Heart 0.38 ± 0.02 0.38 ± 0.02 0.34 ± 0.01 0.37 ± 0.01 0.37 ± 0.02 0.37 ± 0.01 0.38 ± 0.02
Lung 0.57 ± 0.06 0.57 ± 0.11 0.52 ± 0.02 0.56 ± 0.01 0.50 ± 0.03 0.56 ± 0.04 0.54 ± 0.03
Ovary 0.03 ± 0.01 0.02 ± 0.01 0.02 ± 0.00 0.02 ± 0.00 0.02 ± 0.00 0.02 ± 0.00 0.02 ± 0.00
Uterus 0.20 ± 0.01 0.22 ± 0.04 0.19 ± 0.04 0.18 ± 0.06 0.30 ± 0.12 0.19 ± 0.09 0.22 ± 0.10
Male
Liver 3.91 ± 0.10 3.73 ± 0.15 3.66 ± 0.25 3.88 ± 0.28 3.69 ± 0.17
Kidney 0.40 ± 0.01 0.41 ± 0.02 0.39 ± 0.01 0.39 ± 0.02 0.38 ± 0.03
Spleen 0.16 ± 0.02 0.16 ± 0.01 0.15 ± 0.01 0.15 ± 0.01 0.15 ± 0.01
Heart 0.34 ± 0.01 0.31 ± 0.03 0.37 ± 0.01 0.34 ± 0.01 0.36 ± 0.02
Lung 0.44 ± 0.02 0.46 ± 0.03 0.46 ± 0.01 0.43 ± 0.01 0.46 ± 0.02
Testis 0.39 ± 0.04 0.45 ± 0.04 0.45 ± 0.03 0.44 ± 0.04 0.46 ± 0.03
Epididymis 0.15 ± 0.01 0.16 ± 0.01 0.16 ± 0.00 0.16 ± 0.00 0.17 ± 0.00
Vas deferens 0.03 ± 0.00 0.03 ± 0.00 0.03 ± 0.00 0.02 ± 0.00 0.03 ± 0.00
Prostate 0.19 ± 0.02 0.19 ± 0.04 0.18 ± 0.03 0.19 ± 0.04 0.18 ± 0.01
Values expressed as mean ± SEM, n = 5 animals/group. p > 0.05 (ANOVA/Dunnett’s test).
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Toxicological evaluations after repeated exposures are re-
quired by regulatory agencies to characterize the toxicological proﬁle
of any substance (OECD, 2008b). In the present study, after sub-
acute exposure, the animals were active and responsive to stimuli,
with no clinical signs that could be associated with local or sys-
temic toxic effects observed. There were no deaths and the behavior
of animals remained normal for the species. However, the con-
sumption of water and food for the female groups treatedwith OPAC,
at all doses, diminished when compared to the control group. Al-
though themean intake differed statistically, no biological importance
was assigned to this, since the weight gain values (Table 2) did not
differ among groups. Similarly, in the present study, the relative
weights of all organs examined did not vary signiﬁcantly among
groups (Table 3), corroborating the hypothesis of low toxicity of the
oil after subacute exposure.
Clinical biochemistry determinations to investigate major toxic
effects in tissues and, speciﬁcally, effects on kidney and liver, should
be performed and under certain circumstances may provide useful
information. Some enzymes and proteins can be used as indica-
tive of hepatocellular effects (such as ALT, AST, gamma-
glutamyltransferase, bilirubin) (OECD, 2008b; Brandt et al., 2009),
and others as biomarkers of nephron functional injury (creati-
nine, blood urea nitrogen) (Lameire et al., 2005). In this study, there
was no statistical difference in liver or renal parameters (ALT, AST,
bilirubin levels, creatinine and blood urea nitrogen) between the
treated and control groups (Table 4). Some parameters (total protein,
albumin, calcium and cholesterol) were statistically different when
compared to the control group. However, this increase has no clin-
ical signiﬁcance. According to Giknis and Clifford (2006), the values
found in this study are within the normal range for healthy rats at
this age, indicating the absence of liver or renal toxicity.
The hematopoietic system is one of the most susceptible targets
to toxic substances and is an important parameter for assessing the
physiological and pathological status in humans and animals (Li et al.,
2010). Although some parameters observed in this study (eryth-
rocyte count, hematocrit and platelets) showed a statistical difference
in the groups treated with OPAC, the other hematological param-
eters were similar among groups (Table 5). Similarly as in the
biochemical analysis, the observed variations are not biologically
meaningful, since the values are within the normal range for the
species (Giknis and Clifford, 2006), indicating that the OPAC pro-
vided no adverse effects on circulating blood cells or on their
production.
The assessment of pathological changes in the organs of treated
animals, both macro and microscopically, is the basis of a safety as-
sessment (Prabu et al., 2013). In this study, the macroscopic analysis,
the OPAC, at all doses tested, produced no changes in the treated
animals’ vital and reproductive organs in the qualitative analysis.
Similarly, in the histopathological analyses there were no ﬁndings
suggestive of toxic effects (Fig. 1). These results proved to be con-
sistent with biochemical analyses, conﬁrming the safety of using
the OPAC.
4. Conclusion
Previous ﬁndings from our group indicated that OPAC did not
exhibit cytotoxic, genotoxic or mutagenic effects in rats (Traesel et al.,
2014), which corroborates with the results of the present study.
These results demonstrate the absence of acute and subacute tox-
icity as a consequence of the oral treatment with A. aculeata oil,
suggesting that their oral LD50 is higher than 2000 mg/kg. The data
obtained in this study are relevant as they provide for the use of a
Table 4
Biochemical parameters of rats treated orally with oil extract of A. aculeata pulp.
Subacute toxicity
Control 125 mg/kg 250 mg/kg 500 mg/kg Satellite
Female
Aspartate aminotransferase (U/L) 75.60 ± 2.50 68.80 ± 6.90 74.40 ± 14.97 72.60 ± 13.10 80.00 ± 6.01
Alanine aminotransferase (U/L) 39.80 ± 5.93 38.00 ± 2.91 40.20 ± 6.30 45.00 ± 6.96 37.60 ± 2.07
Direct bilirubin (mg/dL) 0.03 ± 0.00 0.04 ± 0.00 0.03 ± 0.01 0.04 ± 0.01 0.02 ± 0.00
Total bilirubin (mg/dL) 0.09 ± 0.01 0.09 ± 0.01 0.09 ± 0.01 0.11 ± 0.02 0.11 ± 0.01
Total protein (g/dL) 6.14 ± 0.35 6.00 ± 0.29 6.16 ± 0.32 6.06 ± 0.16 6.01 ± 0.30
Albumin (g/dL) 4.38 ± 0.08 4.36 ± 0.20 4.48 ± 0.04* 4.40 ± 0.10 4.36 ± 0.20
Globulin (g/dL) 1.72 ± 0.27 1.64 ± 0.28 1.74 ± 0.29 1.64 ± 0.19 1.64 ± 0.26
Albumin/globulin ratio 2.62 ± 0.40 2.70 ± 0.49 2.64 ± 0.37 2.70 ± 0.30 2.70 ± 0.40
Blood urea nitrogen (mg/dL) 56.98 ± 7.53 54.24 ± 5.69 57.92 ± 6.59 51.14 ± 0.90 50.98 ± 1.90
Creatinine (mg/dL) 0.23 ± 0.05 0.20 ± 0.01 0.24 ± 0.05 0.20 ± 0.01 0.24 ± 0.05
Sodium (mmol/dL) 142.44 ± 1.13 141.06 ± 2.34 140.22 ± 0.80 141.42 ± 51.14 139.96 ± 3.90
Potassium (mmol/L) 5.32 ± 0.22 5.22 ± 0.88 5.60 ± 0.53 4.96 ± 0.71 5.07 ± 0.57
Calcium (mg/dL) 10.78 ± 0.87 10.94 ± 0.93 11.10 ± 0.54 10.36 ± 0.31 9.72 ± 0.33*
Cholesterol (mg/dL) 68.98 ± 7.56 71.66 ± 8.61 69.18 ± 7.79 78.84 ± 6.95* 66.71 ± 8.12
Male
Aspartate aminotransferase (U/L) 81.40 ± 7.89 72.00 ± 11.64 73.80 ± 7.31 75.80 ± 7.79 75.00 ± 4.47
Alanine aminotransferase (U/L) 46.80 ± 2.28 40.00 ± 6.04 39.60 ± 5.31 43.20 ± 3.11 43.40 ± 3.36
Direct bilirubin (mg/dL) 0.04 ± 0.00 0.04 ± 0.00 0.03 ± 0.02 0.04 ± 0.01 0.02 ± 0.01
Total bilirubin (mg/dL) 0.11 ± 0.01 0.10 ± 0.01 0.11 ± 0.02 0.09 ± 0.01 0.12 ± 0.01
Total protein (g/dL) 5.84 ± 0.08 5.78 ± 0.26 5.28 ± 0.25** 5.70 ± 0.33 6.16 ± 0.75
Albumin (g/dL) 4.14 ± 0.08 4.04 ± 0.21 3.68 ± 0.20* 4.00 ± 0.20 4.36 ± 0.20
Globulin (g/dL) 1.68 ± 0.08 1.74 ± 0.25 1.60 ± 0.12 1.72 ± 0.21 1.74 ± 0.29
Albumin/globulin ratio 2.42 ± 0.16 2.42 ± 0.43 2.30 ± 0.21 2.38 ± 0.29 2.64 ± 0.85
Blood urea nitrogen (mg/dL) 43.90 ± 7.90 45.00 ± 4.40 44.20 ± 4.93 43.90 ± 5.79 46.76 ± 5.29
Creatinine (mg/dL) 0.20 ± 0.02 0.20 ± 0.10 0.30 ± 0.00 0.25 ± 0.07 0.22 ± 0.04
Sodium (mmol/dL) 142.50 ± 0.99 142.80 ± 1.14 139.68 ± 1.33 138.32 ± 5.01 141.58 ± 2.74
Potassium (mmol/L) 5.08 ± 0.32 5.20 ± 0.67 5.03 ± 0.43 4.56 ± 0.19 4.73 ± 0.23
Calcium (mg/dL) 10.54 ± 0.20 10.30 ± 0.14 9.92 ± 0.23** 10.00 ± 0.35** 10.10 ± 0.15**
Cholesterol (mg/dL) 77.20 ± 9.72 70.00 ± 7.80 69.48 ± 5.10 72.75 ± 14.11 70.96 ± 5.73
Values expressed as mean ± SEM, n = 5 animals/group.
* p < 0.05 (ANOVA/Dunnett’s test) compared with control group; ** p < 0.01 (ANOVA/Dunnett’s test) compared with control group.
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species of great economic and medical importance. However, other
studies based on protocols elaborated by regulatory agencies should
be performed (such as studies of chronic toxicity, reproductive tox-
icity, and others) in order to evaluate the total safety of this plant
in humans.
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Table 5
Hematological parameters of rats treated orally with oil extract of A. aculeata pulp.
Subacute toxicity
Control 125 mg/kg 250 mg/kg 500 mg/kg Satellite
Female
Leukocytes (103/μL) 3.45 ± 1.80 3.07 ± 1.39 3.49 ± 1.68 3.92 ± 1.64 3.82 ± 1.65
Erythrocytes (106/μL) 7.84 ± 0.18 7.99 ± 0.36 8.05 ± 0.27 7.88 ± 0.22 7.96 ± 0.38
Hemoglobin (g/dL) 13.68 ± 0.37 13.62 ± 0.97 14.22 ± 0.64 13.86 ± 0.42 13.44 ± 0.47
Hematocrit (%) 44.58 ± 1.59 44.30 ± 2.80 44.24 ± 2.00 42.62 ± 1.81 41.98 ± 1.17
Platelets (103/μL) 625.80 ± 95.04 547.20 ± 78.26 439.60 ± 124.84 586.00 ± 146.40 517.40 ± 89.54
Red Cell Distribution Width (%) 13.44 ± 0.43 13.86 ± 0.73 13.80 ± 1.28 12.86 ± 0.49 13.22 ± 1.86
Neutrophils (%) 19.64 ± 3.40 19.06 ± 4.98 17.80 ± 3.84 20.56 ± 6.18 20.24 ± 6.67
Lynphocytes (%) 72.86 ± 9.59 75.85 ± 6.36 77.48 ± 5.68 74.14 ± 8.30 73.58 ± 7.32
Monocytes (%) 5.40 ± 6.36 2.98 ± 1.01 3.08 ± 2.76 3.42 ± 3.00 3.92 ± 3.25
Eosinophils (%) 1.44 ± 0.30 1.82 ± 0.98 1.4 ± 0.25 1.58 ± 0.42 2.04 ± 0.81
Basophils (%) 0.66 ± 0.66 0.32 ± 0.30 0.24 ± 0.20 0.3 ± 0.2 0.22 ± 0.17
Male
Leukocytes (103/μL) 4.43 ± 2.02 4.44 ± 1.35 3.98 ± 2.22 4.82 ± 0.36 4.55 ± 1.48
Erythrocytes (106/μL) 8.92 ± 0.32 8.75 ± 0.11 8.38 ± 0.23* 8.72 ± 0.13 8.76 ± 0.27
Hemoglobin (g/dL) 15.10 ± 0.56 14.64 ± 0.18 14.30 ± 0.45 14.90 ± 0.38 15.15 ± 0.64
Hematocrit (%) 47.24 ± 1.87 45.56 ± 0.43 43.54 ± 1.57** 44.96 ± 1.58 44.98 ± 1.66
Platelets (103/μL) 611.80 ± 137.77 647.20 ± 55.16 556.60 ± 83.61** 594.80 ± 58.97 612.80 ± 71.07
Red Cell Distribution Width (%) 14.24 ± 0.91 13.74 ± 1.07 13.54 ± 0.29 14.18 ± 1.07 14.80 ± 1.07
Neutrophils (%) 17.52 ± 3.86 21.98 ± 12.37 23.56 ± 5.37 24.12 ± 3.80 14.76 ± 2.38
Lynphocytes (%) 79.32 ± 3.66 74.98 ± 13.06 71.46 ± 8.31 72.66 ± 3.97 82.36 ± 2.28
Monocytes (%) 2.14 ± 0.46 2.06 ± 1.94 3.56 ± 2.92 1.98 ± 0.61 1.52 ± 0.37
Eosinophils(%) 0.84 ± 0.33 0.82 ± 0.16 1.22 ± 0.51 1.2 ± 0.58 1.16 ± 0.16
Basophils (%) 0.18 ± 0.10 0.16 ± 0.14 0.20 ± 0.10 0.04 ± 0.08 0.20 ± 0.20
Values expressed as mean ± SEM, n = 5 animals/group.
* p < 0.05 (ANOVA/Dunnett’s test) compared with control group; ** p < 0.01 (ANOVA/Dunnett’s test) compared with control group.
 Liver Kidney Lung 
Control 
   
Group 1000 mg/kg 
(Satellite group) 
   
A C E 
B D F 
Fig. 1. Histopathological analysis of organs treated with oil extract of A. aculeata pulp in the subacute toxicity (H&E ×100). (A and B) liver; (C and D) kidney; (E and F) lung.
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